Tethys BioScience

About:

Tethys BioScience develops and commercializes biological markers for use in the diagnosis of metabolic diseases.

Twitter/X: HDLtweets

Top Investors: Intel Capital, Kleiner Perkins, Silicon Valley Bank, Mohr Davidow Ventures, Aeris Capital

Description:

Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.

Total Funding Amount:

$75.4M

Headquarters Location:

Emeryville, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)tethysbio.com

Founders:

Dave Hodgson, Mickey Urdea

Number of Employees:

51-100

Last Funding Date:

2012-01-01

IPO Status:

Private

Industries: